Status:
COMPLETED
Study of Compound Nanxing Zhitong Ointment in the Treatment of Chronic Pain in Musculoskeletal System
Lead Sponsor:
Jiangsu Kanion Pharmaceutical Co., Ltd
Conditions:
Chronic Primary Musculoskeletal Pain
Eligibility:
All Genders
Brief Summary
A prospective cohort study on the treatment of chronic pain in the musculoskeletal system with Compound Nanxing Pain Relief Ointment. This study adopted an observational research design. Through a coh...
Eligibility Criteria
Inclusion
- For those who visit the orthopedics department, rheumatology department, or pain clinic:
- Those whose pain is located in the musculoskeletal system as classified in International Classification of Diseases 11th Revision(ICD-11) for chronic pain, and occurs in the neck, shoulders, waist, back, or limbs;
- Those who meet the diagnostic criteria of "cold syndrome" in traditional Chinese medicine, and their chronic pain worsens or occurs when exposed to cold;
- Those with continuous or intermittent pain lasting more than 3 months, and without surgical indications.
Exclusion
- None
Key Trial Info
Start Date :
October 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2024
Estimated Enrollment :
3029 Patients enrolled
Trial Details
Trial ID
NCT07200362
Start Date
October 30 2021
End Date
February 28 2024
Last Update
October 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Third Affiliated Hospital of Beijing University of Chinese Medicine
Beijing, Beijing Municipality, China, 100029